Sodium butyrate reduces colitogenic immunoglobulin A-Coated bacteria and modifies the composition of microbiota in IL-10 deficient mice

Nutrients

Volumn 8, Issue 12, 2016, Pages

  Zhang, Tenghui ^a,b   Ding, Chao ^b   Zhao, Mingli ^a   Dai, Xujie ^b   Yang, Jianbo ^b   Li, Yi ^b   Gu, Lili ^b   Wei, Yao ^b   Gong, Jianfeng ^a,b   Zhu, Weiming ^b   Li, Ning ^b   Li, Jieshou ^b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

Colitis; IL 10 mice; Immunoglobulin A coated bacteria; Microbiota composition; Sodium butyrate

Indexed keywords

BUTYRIC ACID; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 6; SHORT CHAIN FATTY ACID; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ARTICLE; BIODIVERSITY; CELL INFILTRATION; COLITIS; CONTROLLED STUDY; DISEASE SEVERITY; ERYSIPELOTRICHACEAE; FEMALE; FIRMICUTES; FLOW CYTOMETRY; GENE EXPRESSION; HISTOLOGY; INTESTINE FLORA; LACTOBACILLACEAE; MALE; MOLLICUTES; MOUSE; NONHUMAN; PREVOTELLA; PROTEOBACTERIA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; CHEMICALLY INDUCED; COLON; DRUG EFFECTS; GENETICS; GERMFREE ANIMAL; INTESTINE; KNOCKOUT MOUSE; METABOLISM; MICROBIOLOGY; MICROFLORA; RANDOMIZATION; STOMACH JUICE;

ANIMALS; BUTYRIC ACID; COLITIS; COLON; FEMALE; GASTROINTESTINAL CONTENTS; IMMUNOGLOBULIN A; INTERLEUKIN-10; INTESTINES; MALE; MICE; MICE, KNOCKOUT; MICROBIOTA; RANDOM ALLOCATION; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 84997124317     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8120728     Document Type: Article

References (46)

1. Elson, C.O.; Cong, Y.; McCracken, V.J.; Dimmitt, R.A.; Lorenz, R.G.; Weaver, C.T.; Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol. Rev. 2005, 206, 260–276. [CrossRef] [PubMed]
2. Willing, B.P.; Dicksved, J.; Halfvarson, J.; Andersson, A.F.; Lucio, M.; Zheng, Z.; Engstrand, L.; A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010, 139, 1844–1854. [CrossRef] [PubMed]
3. Maharshak, N.; Packey, C.D.; Ellermann, M.; Manick, S.; Siddle, J.P.; Huh, E.Y.; Carroll, I.M.; Altered enteric microbiota ecology in interleukin 10-deficient mice during development and progression of intestinal inflammation. Gut Microb. 2013, 4, 316–324. [CrossRef] [PubMed]
4. Kang, S.; Denman, S.E.; Morrison, M.; Yu, Z.; Dore, J.; Leclerc, M.; McSweeney, C.S.; Dysbiosis of fecal microbiota in Crohn’s disease patients as revealed by a custom phylogenetic microarray. Inflamm. Bowel Dis. 2010, 16, 2034–2042. [CrossRef] [PubMed]
5. Manichanh, C.; Rigottier-Gois, L.; Bonnaud, E.; Gloux, K.; Pelletier, E.; Frangeul, L.; Roca, J.; Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach. Gut 2006, 55, 205–211. [CrossRef] [PubMed]
6. Lupp, C.; Robertson, M.L.; Wickham, M.E.; Sekirov, I.; Champion, O.L.; Gaynor, E.C.; Finlay, B.B.; Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007, 2, 119–129. [CrossRef] [PubMed]
7. Ambrose, N.S.; Johnson, M.; Burdon, D. W.; Keighley, M.R.; Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn’s disease surgery. Br. J. Surg. 1984, 71, 623–625. [CrossRef] [PubMed]
8. Takesue, Y.; Ohge, H.; Uemura, K.; Imamura, Y.; Murakami, Y.; Yokoyama, T.; Sueda, T.; Bacterial translocation in patients with Crohn’s disease undergoing surgery. Dis. Colon Rectum 2002, 45, 1665–1671. [CrossRef] [PubMed]
9. Palm, N. W.; De Zoete, M.R.; Cullen, T. W.; Barry, N.A.; Stefanowski, J.; Hao, L.; Ruggiero, E.; Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell 2014, 158, 1000–1010. [CrossRef] [PubMed]
10. Macpherson, A.J.; Uhr, T.; Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004, 303, 1662–1665. [CrossRef] [PubMed]
11. Pabst, O.; New concepts in the generation and functions of IgA. Nat. Rev. Immunol. 2012, 12, 821–832. [CrossRef] [PubMed]
12. Ley, R.E.; Hamady, M.; Lozupone, C.; Turnbaugh, P.J.; Ramey, R.R.; Bircher, J.S.; Gordon, J.I.; Evolution of mammals and their gut microbes. Science 2008, 320, 1647–1651. [CrossRef] [PubMed]
13. De Filippo, C.; Cavalieri, D.; Di Paola, M.; Ramazzotti, M.; Poullet, J.B.; Massart, S.; Lionetti, P.; Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Nat. Acad. Sci. USA 2010, 107, 14691–14696. [CrossRef] [PubMed]
14. Liu, L.; Li, Y.H.; Niu, Y.B.; Sun, Y.; Guo, Z.J.; Li, Q.; Mei, Q.B.; An apple oligogalactan prevents against inflammation and carcinogenesis by targeting LPS/TLR4/NF-kB pathway in a mouse model of colitis-associated colon cancer. Carcinogenesis 2010, 31, 1822–1832. [CrossRef] [PubMed]
15. Ye, M.B.; Lim, B.O.; Dietary pectin regulates the levels of inflammatory cytokines and immunoglobulins in interleukin-10 knockout mice. J. Agric. Food Chem. 2010, 58, 11281–11286. [CrossRef] [PubMed]
16. Bassaganya-Riera, J.; DiGuardo, M.; Viladomiu, M.; De Horna, A.; Sanchez, S.; Einerhand, A. W.; Hontecillas, R.; Soluble fibers and resistant starch ameliorate disease activity in interleukin-10-deficient mice with inflammatory bowel disease. J. Nutr. 2011, 141, 1318–1325. [CrossRef] [PubMed]
17. Roediger, W.E.; Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980, 21, 793–798. [CrossRef] [PubMed]
18. Binder, H.J.; Mehta, P.; Short-chain fatty acids stimulate active sodium and chloride absorption in vitro in the rat distal colon. Gastroenterology 1989, 96, 989–996. [CrossRef]
19. Morgan, X.C.; Tickle, T.L.; Sokol, H.; Gevers, D.; Devaney, K.L.; Ward, D.V.; Bousvaros, A.; Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012, 13, R79. [CrossRef] [PubMed]
20. Erickson, A.R.; Cantarel, B.L.; Lamendella, R.; Darzi, Y.; Mongodin, E.F.; Pan, C.; Raes, J.; Integrated metagenomics/metaproteomics reveals human host-microbiota signatures of Crohn’s disease. PLoS ONE 2012, 7, e49138. [CrossRef] [PubMed]
21. De Preter, V.; Joossens, M.; Ballet, V.; Shkedy, Z.; Rutgeerts, P.; Vermeire, S.; Verbeke, K.; Metabolic profiling of the impact of oligofructose-enriched inulin in Crohn’s disease patients: A double-blinded randomized controlled trial. Clin. Transl. Gastroenterol. 2013, 4, e30. [CrossRef] [PubMed]
22. Machiels, K.; Joossens, M.; Sabino, J.; De Preter, V.; Arijs, I.; Eeckhaut, V.; Ferrante, M.; A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2014, 63, 1275–1283. [CrossRef] [PubMed]
23. Smith, P.M.; Howitt, M.R.; Panikov, N.; Michaud, M.; Gallini, C.A.; Bohlooly, Y.M.; Garrett, W.S.; The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013, 341, 569–573. [CrossRef] [PubMed]
24. Berg, D.J.; Davidson, N.; Kuhn, R.; Muller, W.; Menon, S.; Holland, G.; Rennick, D.; Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Investig. 1996, 98, 1010–1020. [CrossRef] [PubMed]
25. Zheng, X.; Qiu, Y.; Zhong, W.; Baxter, S.; Su, M.; Li, Q.; Zeisel, S.H.; A targeted metabolomic protocol for short-chain fatty acids and branched-chain amino acids. Metabolomics 2013, 9, 818–827. [CrossRef] [PubMed]
26. Geremia, A.; Arancibia-Carcamo, C.V.; Fleming, M.P.; Rust, N.; Singh, B.; Mortensen, N.J.; Powrie, F.; IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J. Exp. Med. 2011, 208, 1127–1133. [CrossRef] [PubMed]
27. Fadrosh, D. W.; Ma, B.; Gajer, P.; Sengamalay, N.; Ott, S.; Brotman, R.M.; Ravel, J.; An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform. Microbiome 2014, 2, 6. [CrossRef] [PubMed]
28. Wedlake, L.; Slack, N.; Andreyev, H.J.; Whelan, K.; Fiber in the treatment and maintenance of inflammatory bowel disease: A systematic review of randomized controlled trials. Inflamm. Bowel Dis. 2014, 20, 576–586. [CrossRef] [PubMed]
29. Thomsen, L.L.; Roberton, A.M.; Wong, J.; Lee, S.P.; Tasman-Jones, C.; Intra-caecal short chain fatty acids are altered by dietary pectin in the rat. Digestion 1984, 29, 129–137. [CrossRef] [PubMed]
30. Vieira, E.L.; Leonel, A.J.; Sad, A.P.; Beltrao, N.R.; Costa, T.F.; Ferreira, T.M.; Alvarez-Leite, J.I.; Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. J. Nutr. Biochem. 2012, 23, 430–436. [CrossRef] [PubMed]
31. Waldecker, M.; Kautenburger, T.; Daumann, H.; Veeriah, S.; Will, F.; Dietrich, H.; Schrenk, D.; Histone-deacetylase inhibition and butyrate formation: Fecal slurry incubations with apple pectin and apple juice extracts. Nutrition 2008, 24, 366–374. [CrossRef] [PubMed]
32. Zacharias, B.; Kerler, A.; Drochner, W.; The influence of 5% and 10% dietary apple pectin on parameters of fermentation in faeces and caecal digesta of weaning pigs. Arch. Anim. Nutr. 2004, 58, 149–156. [CrossRef] [PubMed]
33. Licht, T.R.; Hansen, M.; Bergstrom, A.; Poulsen, M.; Krath, B.N.; Markowski, J.; Wilcks, A.; Effects of apples and specific apple components on the cecal environment of conventional rats: Role of apple pectin. BMC Microbial. 2010, 10, 13. [CrossRef] [PubMed]
34. Takahashi, K.; Nishida, A.; Fujimoto, T.; Fujii, M.; Shioya, M.; Imaeda, H.; Sugimoto, M.; Reduced abundance of butyrate-producing bacteria species in the fecal microbial community in Crohn’s disease. Digestion 2016, 93, 59–65. [CrossRef] [PubMed]
35. Baumgart, M.; Dogan, B.; Rishniw, M.; Weitzman, G.; Bosworth, B.; Yantiss, R.; Berg, D.; Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn’s disease involving the ileum. ISME J. 2007, 1, 403–418. [CrossRef] [PubMed]
36. Walker, A. W.; Sanderson, J.D.; Churcher, C.; Parkes, G.C.; Hudspith, B.N.; Rayment, N.; Petrovska, L.; High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease. BMC Microbial. 2011, 11, 7. [CrossRef] [PubMed]
37. Elinav, E.; Strowig, T.; Kau, A.L.; Henao-Mejia, J.; Thaiss, C.A.; Booth, C.J.; Flavell, R.A.; NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 2011, 145, 745–757. [CrossRef] [PubMed]
38. Scher, J.U.; Sczesnak, A.; Longman, R.S.; Segata, N.; Ubeda, C.; Bielski, C.; Huttenhower, C.; Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2013, 2, e01202. [CrossRef] [PubMed]
39. Kullberg, M.C.; Ward, J.M.; Gorelick, P.L.; Caspar, P.; Hieny, S.; Cheever, A.; Sher, A.; Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect. Immun. 1998, 66, 5157–5166. [PubMed]
40. Slack, E.; Balmer, M.L.; Fritz, J.H.; Hapfelmeier, S.; Functional flexibility of intestinal IgA-broadening the fine line. Front. Immunol. 2012, 3, 100. [CrossRef] [PubMed]
41. Van Der Waaij, L.A.; Mesander, G.; Limburg, P.C.; Van der Waaij, D.; Direct flow cytometry of anaerobic bacteria in human feces. Cytometry 1994, 16, 270–279. [CrossRef] [PubMed]
42. Alipour, M.; Zaidi, D.; Valcheva, R.; Jovel, J.; Martinez, I.; Sergi, C.; Carroll, M. W. Mucosal barrier depletion and loss of bacterial diversity are primary abnormalities in paediatric ulcerative colitis. J. Crohn’s Colitis 2016, 10, 462–471. [CrossRef] [PubMed]
43. Andoh, A.; Kuzuoka, H.; Tsujikawa, T.; Nakamura, S.; Hirai, F.; Suzuki, Y.; Matsumoto, T.; Multicenter analysis of fecal microbiota profiles in Japanese patients with Crohn’s disease. J. Gastroenterol. 2012, 47, 1298–1307. [CrossRef] [PubMed]
44. Maukonen, J.; Kolho, K.L.; Paasela, M.; Honkanen, J.; Klemetti, P.; Vaarala, O.; Saarela, M.; Altered fecal microbiota in paediatric inflammatory bowel disease. J. Crohn’s Colitis 2015, 9, 1088–1095. [CrossRef] [PubMed]
45. Bassett, S.A.; Young, W.; Barnett, M.P.; Cookson, A.L.; McNabb, W.C.; Roy, N.C.; Changes in composition of caecal microbiota associated with increased colon inflammation in interleukin-10 gene-deficient mice inoculated with Enterococcus species. Nutrients 2015, 7, 1798–1816. [CrossRef] [PubMed]
46. Moayyedi, P.; Surette, M.G.; Kim, P.T.; Libertucci, J.; Wolfe, M.; Onischi, C.; Lee, C.H.; Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 2015, 149, 102–109. [CrossRef] [PubMed]